Edwards Lifesciences Corporation (BMV:EW)

Paramount Global Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,273	3,045	1,132	769	862.8	1,183
Short-Term Investments	789.4	930.7	500.5	446.3	604	219.4
Cash & Short-Term Investments	4,062	3,976	1,633	1,215	1,467	1,403
Cash Growth	104.15%	143.50%	34.35%	-17.15%	4.58%	-7.54%
Accounts Receivable	697	609.1	771.5	643	582.2	514.6
Other Receivables	205.6	118.3	56.6	56.1	82.7	88.2
Receivables	902.6	727.4	828.1	699.1	664.9	602.8
Inventory	1,142	1,087	903.5	875.5	726.7	802.3
Prepaid Expenses	110	121	128.8	110	85.2	75.1
Restricted Cash	1.2	3.2	3.3	0.5	1.5	16.6
Other Current Assets	359.5	371.2	539.2	195.4	235.6	191.6
Total Current Assets	6,577	6,285	4,036	3,096	3,181	3,091
Property, Plant & Equipment	1,826	1,784	1,675	1,725	1,639	1,489
Long-Term Investments	298.5	307.9	583.9	1,239	1,834	801.6
Goodwill	1,777	1,777	1,145	1,164	1,168	1,173
Other Intangible Assets	1,173	1,177	399.4	285.2	323.6	331.4
Long-Term Deferred Tax Assets	1,082	992.1	749.4	484	246.7	230.9
Other Long-Term Assets	550.2	603.1	619.2	299.1	110.8	119.6
Total Assets	13,489	13,055	9,363	8,293	8,503	7,237
Accounts Payable	162.1	197.4	186.6	201.9	204.5	196.5
Accrued Expenses	839.1	790.4	667.2	593.1	643.4	516
Current Portion of Leases	25.9	23.4	22.9	25.5	25.5	27.2
Current Income Taxes Payable	146.3	286.6	52.7	50.6	30.6	18.6
Current Unearned Revenue	36.8	53.7	-	-	-	-
Other Current Liabilities	194.5	153.7	266	151.3	128.3	135.6
Total Current Liabilities	1,405	1,505	1,195	1,022	1,032	893.9
Long-Term Debt	598	597.7	597	596.3	595.7	595
Long-Term Leases	78.7	78.9	65.2	69.5	69.1	72.7
Other Long-Term Liabilities	780.6	778.5	750	774.1	928.6	1,048
Total Liabilities	2,882	2,992	2,644	2,486	2,667	2,663
Common Stock	657.6	654.8	650.5	646.3	642	636.4
Additional Paid-In Capital	2,750	2,613	2,274	1,969	1,700	1,438
Retained Earnings	13,858	13,167	8,992	7,590	6,068	4,565
Treasury Stock	-6,456	-6,192	-5,025	-4,144	-2,417	-1,904
Comprehensive Income & Other	-264.1	-244.5	-242.8	-254.9	-157.7	-161.1
Total Common Equity	10,545	9,998	6,650	5,807	5,836	4,574
Minority Interest	61.2	64.5	69.4	-	-	-
Shareholders' Equity	10,607	10,063	6,719	5,807	5,836	4,574
Total Liabilities & Equity	13,489	13,055	9,363	8,293	8,503	7,237
Total Debt	702.6	700	685.1	691.3	690.3	694.9
Net Cash (Debt)	3,365	3,281	947.7	524	776.5	707.7
Net Cash Growth	159.46%	246.25%	80.86%	-32.52%	9.72%	-15.56%
Net Cash Per Share	5.69	5.48	1.56	0.84	1.23	1.12
Filing Date Shares Outstanding	587.1	587.9	601.3	608.31	623.21	624.52
Total Common Shares Outstanding	587.9	588.6	601.1	608.3	624.1	624.3
Working Capital	5,173	4,780	2,840	2,073	2,148	2,197
Book Value Per Share	17.94	16.99	11.06	9.55	9.35	7.33
Tangible Book Value	7,596	7,045	5,106	4,357	4,344	3,070
Tangible Book Value Per Share	12.92	11.97	8.49	7.16	6.96	4.92
Land	-	123.9	112.4	116.3	116.5	97.6
Buildings	-	1,340	1,189	1,189	1,010	881.5
Machinery	-	689.4	618.6	735	652.6	607.1
Construction In Progress	-	244	292.5	255.2	333.8	313.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.